Showing 681 - 700 results of 2,482 for search '"hepatitis"', query time: 0.24s Refine Results
  1. 681

    Formulation Design and Cell Cytotoxicity of Curcumin-Loaded Liposomal Solid Gels for Anti-Hepatitis C Virus by Helmy Yusuf, Erlyn K. D. D. Novitasari, Ni L. W. Purnami, Adhe W. Mahbub, Retno Sari, Dwi Setyawan

    Published 2022-01-01
    “…Anti-inflammatory and anti-hepatitis C virus (HCV) activities have been associated with CUR. …”
    Get full text
    Article
  2. 682
  3. 683

    Ciliated Hepatic Foregut Cyst: A Report of a Case Incidentally Discovered during Transplant Evaluation by Thomas Enke, Wuttiporn Manatsathit, Shaheed Merani, Kurt Fisher

    Published 2019-01-01
    “…Ciliated hepatic foregut cyst (CHFC) is a rare benign cyst of the liver derived from an embryonic remnant of foregut epithelium. …”
    Get full text
    Article
  4. 684

    Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C by Fareed B. Kamar, T. Lee-Ann Hawkins

    Published 2016-01-01
    “…We also summarize previously reported cases of ANCA positivity in the context of endocarditis and hepatitis C infections.…”
    Get full text
    Article
  5. 685

    Rutaecarpine alleviates hepatic ischemia‒reperfusion injury in liver transplantation by inhibiting inflammatory response and oxidative stress by Yan Liu, Yan Liu, Feng Qi, Lun-Jian Xiang, Zhu-Jun Yi, Sheng-Wei Li

    Published 2025-02-01
    “…The aim of this study was to investigate whether Rut can alleviate hepatic IRI in liver transplantation (LT) and to explore the underlying mechanisms.MethodsRat DCD LT and oxygen-glucose deprivation/reoxygenation (OGD/R) cell models were established to clarify the effect of Rut on hepatic IRI. …”
    Get full text
    Article
  6. 686

    Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience) by I. Yu. Pirogova, N. B. Kovaleva, E. P. Patlusov, E. S. Radchenko

    Published 2018-08-01
    “…Overall 164 patients with hepatitis C viruses (HCV) genotypes 1, 2 and 3 in 4 medical centers received antiviral therapy. …”
    Get full text
    Article
  7. 687

    Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C by L. Tang, M. Kamat, A. Shukla, M. Vora, C. Kalal, S. Kottilil, S. Shah

    Published 2018-01-01
    “…Background. Chronic hepatitis C infection is a major cause for liver failure and liver cancer and can be treated with highly effective all oral directly acting antiviral (DAA) drugs. …”
    Get full text
    Article
  8. 688

    Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia by M. V. Sokolova, Ye. Ye. Starostina, T. N. Krasnova, L. M. Samokhodskaya, T. P. Rozina, V. G. Avdeyev, M. G. Artemova, Ye. B. Yarovaya, N. A. Mukhin

    Published 2018-08-01
    “…To estimate the effect of carriage of endothelial dysfunction and hemostasis gene allelic variants on development of cryoglobulinemic vasculitis (CryoVas) and its clinical symptoms in patients with chronic hepatitis C (CHC). Material and methods. Original study included overall 72 patients with CHC and cryoglobulinemia: 21 patients had CryoVas, 51 - CHC without vasculitis. …”
    Get full text
    Article
  9. 689

    Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma by Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam

    Published 2015-01-01
    “…However, because of the resistance rate to telbivudine (TLV), the current guidelines recommend entecavir (ETV) or tenofovir (TNV) as the first-line therapy for chronic hepatitis B. We investigated the short term virologic efficacy of TLV in comparison with ETV as the first-line agent of HBV suppression in HBV-related advanced HCC patients. …”
    Get full text
    Article
  10. 690
  11. 691

    Expression of Toll-Like Receptors 2 and 4 and Related Cytokines in Patients with Hepatic Cystic and Alveolar Echinococcosis by Tuerhongjiang Tuxun, Hai-Zhang Ma, Shadike Apaer, Heng Zhang, Amina Aierken, Yu-Peng Li, Ren-Yong Lin, Jin-Ming Zhao, Jin-Hui Zhang, Hao Wen

    Published 2015-01-01
    “…The mRNA expression levels of TLR2 and TLR4 in blood and hepatic tissue and plasma levels related cytokines were detected by using ELISA. …”
    Get full text
    Article
  12. 692
  13. 693
  14. 694

    A Rare Occurrence of Primary Hepatic Leiomyosarcoma Associated with Epstein Barr Virus Infection in an AIDs Patient by Haritha Chelimilla, Kanthi Badipatla, Ariyo Ihimoyan, Masooma Niazi

    Published 2013-01-01
    “…Primary hepatic leiomyosarcoma is exceedingly rare accounting for less than 1% of the hepatic tumors. …”
    Get full text
    Article
  15. 695

    A Potential Prognostic Indicator of Fulminant Hepatic Failure: A Valuable Adjunct in Preliver Transplant Assessment by B Yacyshyn, CM Cheung, D Gordon Malkin, SC Pappas

    Published 1994-01-01
    “…The use of thyroid function tests as a method of monitoring patients with fulminant hepatic failure has been previously proposed. The use of these indices in two cases with fulminant hepatic failure are described. …”
    Get full text
    Article
  16. 696
  17. 697

    Acute effects on hepatic biomarkers in the freshwater native fish Aequidens metae exposed to polycyclic aromatic hydrocarbons by W. Corredor-Santamaría, I.C. Calderón-Delgado, Z. Arbeli, J.M. Navas, Y.M. Velasco-Santamaría

    Published 2023-10-01
    “…The aim of the present study was to evaluate the hepatic and erythrocyte response in Aequidens metae, a detritivorous fish, exposed to polycyclic aromatic hydrocarbons in terms of morphological, biochemical, and genotoxic changes.METHODS: Juveniles of Aequidens metae were exposed to 50 microgram per gram body weight of beta-naphthoflavone, 100 microgram per gram of naphthalene, 50 microgram per gram of phenanthrene and 10 microgram per gram of benzo[a]pyrene, for 72 hours. …”
    Get full text
    Article
  18. 698
  19. 699

    Plasmapheresis for Pembrolizumab-Induced Hepatitis in a Patient with Squamous Cell Carcinoma and Prior Orthotopic Liver Transplantation by Sanaa Al-Nattah, Kusum Lata Sharma, Matthew Caldis, Erin Spengler, William N. Rose

    Published 2022-01-01
    “…We present a case of pembrolizumab-induced hepatitis in a patient with squamous cell carcinoma and prior orthotopic liver transplantation. …”
    Get full text
    Article
  20. 700